Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma-Reference-Cited by-同舟云学术

Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma

Published:2023-04 Issue:4 Volume:151 Page:966-975
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Matschiner Gabriele^ORCID,Fitzgerald Mary F.,Moebius Ulrich,Hohlbaum Andreas M.,Gille Hendrik,Jensen Kristian,Kirchfeld Klaus,Rattenstetter Barbara,Laforge Alice,Bel Aiba Rachida S.,Ciccotosto Joe,Nyugen Hong,Foster Martyn L.,Snouwaert John N.,Nguyen MyTrang,Koller Beverly H.,Matis Louis,Anderson Gary P.,Olwill Shane A.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. Expression of the IL-4 receptor α-subunit is increased in bronchial biopsy specimens from atopic and nonatopic asthmatic subjects;Kotsimbos;J Allergy Clin Immunol,1998

2. T-helper type 2–driven inflammation defines major subphenotypes of asthma;Woodruff;Am J Respir Crit Care Med,2009

3. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease;Anderson;Lancet,2008

4. Type 2 inflammation in asthma—present in most, absent in many;Fahy;Nat Rev Immunol,2015

5. Targeting key proximal drivers of type 2 inflammation in disease;Gandhi;Nat Rev Drug Discov,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Developments in Aerosol Pulmonary Drug Delivery: New Technologies, New Cargos, and New Targets;Annual Review of Biomedical Engineering;2024-07-03

2. A novel inhalable nanobody targeting IL-4Rα for the treatment of asthma;Journal of Allergy and Clinical Immunology;2024-06

3. Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives;Pharmaceutics;2024-01-24

4. Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy;Advanced Drug Delivery Reviews;2023-11

5. Inhalable Nanofitin demonstrates high neutralization of SARS-CoV-2 virus via direct application in respiratory tract;Molecular Therapy;2023-10